Stocks Health care OLMA
NASDAQ · Health careOlema Pharmaceuticals, Inc. (OLMA)
It posted a net loss of $204.6M. At June 30, 2026 it held $48.6M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 10, 2026.
What Olema Pharmaceuticals, Inc. does
Olema Pharmaceuticals, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker OLMA.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$162.5M | -$1.87 | n/a |
| 2024 | n/a | -$129.5M | -$2.20 | -$104.5M |
| 2023 | n/a | -$96.7M | -$2.14 | n/a |
| 2022 | n/a | -$104.8M | -$2.62 | -$82.4M |
| 2021 | n/a | -$71.1M | -$1.80 | -$52.3M |
| 2021 | n/a | -$22.1M | -$3.42 | -$19.9M |
Latest SEC filings
What Olema Pharmaceuticals, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 13, 2026
- August 10, 2026Quarterly report 10-Q · period to June 30, 2026
- August 10, 2026
- August 6, 2026Passive stake changed SCHEDULE 13G/A
- July 29, 2026Passive stake changed SCHEDULE 13G/A
- June 23, 2026
- May 26, 2026
- May 21, 2026
- May 15, 2026Passive stake changed SCHEDULE 13G/A
- May 15, 2026Passive stake changed SCHEDULE 13G/A
Questions about OLMA
What does Olema Pharmaceuticals, Inc. do?
Olema Pharmaceuticals, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker OLMA.
Is Olema Pharmaceuticals, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $204.6M.
When did Olema Pharmaceuticals, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 10, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 2, 2026.
Similar companies
Follow OLMA
Get an email when Olema Pharmaceuticals, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow OLMA: get an email when it filesWhere the numbers come from
Financial figures are the values Olema Pharmaceuticals, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.